Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis
Authors:
- Jozef HatokJHJozef Hatok
- Pavol ZuborPavol Zubor
- Silvester GaloSGSilvester Galo
- Renata KirschnerovaRKRenata Kirschnerova
- Dusan DobrotaDDDusan Dobrota
- Jan DankoJDJan Danko
- Peter RacayPRPeter Racay
- 17 June 2010
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 27 (5) , 331-336
Abstract
Endometriosis (ENDs) and adenomyosis (ADNs) are estrogen-dependent diseases. The aim of this study was to determine the clinical usefulness of examining endometrial biopsy specimens for aromatase cytochrome P450 (CYP19) as a diagnostic importance for endometriosis and adenomyosis. In general, the RT-PCR analyses of 101 samples revealed increased aromatase mRNA expression in eutopic endometrium in women with endometriosis and adenomyosis compared to healthy controls (p = 0.0002). The highest number of positive cases (93.3%) of CYP19 mRNA expression was detected in women with advanced disease stages. Concrete expression of CYP19 mRNA level in controls was 0.68 compared to patients with ADNs (1.21), ENDsL stage I-II (1.15) and ENDsA stage III-IV (1.65) (p < 0.0001), respectively. The possible influence of increased body mass index on aromatase expression in each group showed in controls an insignificant slight increase of aromatase expression, contrary to cases where this trend was the opposite. The results point to the higher (2.45-fold) difference in aromatase expression in patients with endometriosis stage III-IV compared to controls and provide direct evidence that screening for eutopic endometrial aromatase expression in combination with clinical data could be of discriminative value in the prediction of estrogen-dependent diseases, independent from body mass index.Keywords
This publication has 20 references indexed in Scilit:
- Absence of aromatase protein and mRNA expression in endometriosisHuman Reproduction, 2009
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired MetabolismThe Journal of Clinical Endocrinology & Metabolism, 2009
- The relationship of endometriosis and ovarian malignancy: a reviewFertility and Sterility, 2008
- Adenomyosis: the pathophysiology of an oestrogen-dependent diseaseBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- A predictive model for endometriosisHuman Reproduction, 2005
- P450 arom y microambiente estrogénico en endometrios eutópicos de mujeres con endometriosisRevista médica de Chile, 2004
- Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosisFertility and Sterility, 2002
- Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine TissueThe Journal of Clinical Endocrinology & Metabolism, 2002
- Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosisFertility and Sterility, 1999
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985